During the past decade, Buffalo Medical Group conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Buffalo Medical Group" #1 collaborator was "Biogen" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Buffalo Medical Group" are "Cardiovascular Disease" (2 trials), "Moderate to Severe Chronic Plaque Psoriasis" (1 trials) and "Psoriasis" (1 trials). Many other conditions were trialed in "Buffalo Medical Group" in a lesser frequency.

Most popular intervention types in "Buffalo Medical Group" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "Alefacept" (1 trials). Other intervention names were less common.

The vast majority of trials in "Buffalo Medical Group" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Buffalo Medical Group". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Buffalo Medical Group, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Buffalo Medical Group, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".